# Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

> **NCT00772811** · PHASE2 · COMPLETED · sponsor: **Cooperative Study Group A for Hematology** · enrollment: 38 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Lymphoma
- Multiple Myeloma

## Interventions

- **DRUG:** Flu-Mel

## Key facts

- **NCT ID:** NCT00772811
- **Lead sponsor:** Cooperative Study Group A for Hematology
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772811, "Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00772811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*